AVITA Med Ltd/S (AVMXY) Given a $65.00 Price Target by Cantor Fitzgerald Analysts

Share on StockTwits

Cantor Fitzgerald set a $65.00 target price on AVITA Med Ltd/S (OTCMKTS:AVMXY) in a research report report published on Thursday, September 20th. The brokerage currently has a buy rating on the medical device company’s stock.

Shares of OTCMKTS AVMXY traded up $0.18 during mid-day trading on Thursday, hitting $1.65. 188,068 shares of the stock traded hands, compared to its average volume of 80,825. AVITA Med Ltd/S has a 52 week low of $0.75 and a 52 week high of $2.15.

AVITA Med Ltd/S Company Profile

Avita Medical Limited, a medical device company, develops and distributes regenerative products for the treatment of a range of wounds, scars, and skin defects in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. Its patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin.

See Also: Trading Strategy Methods and Types

Receive News & Ratings for AVITA Med Ltd/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AVITA Med Ltd/S and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.